As shown in Figure 1, significantly high levels of lncRNA HULC, MALAT1, Linc00152, PTTG3P, SPRY4-IT1, UBE2CP3, and UCA1 were observed in patients with HCC when compared with healthy controls, CHB patients, or LC patients. This evidence concerns the gene SPRY4 and hepatocellular carcinoma.